ERBB2 and breast carcinoma: Traditionally, according to immunohistochemistry for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor2 (HER2), breast cancer is classified into the luminal A, luminal B, HER2-positive, and triple-negative subtypes [4].